" class="no-js "lang="en-US"> Olympus - Medtech Alert
Wednesday, June 18, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Olympus | Pharmtech Focus

Olympus

About Olympus

Olympus

Related Story

Mergers & Aquisitions

 Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical | MTA

Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical

February 24 2023

Olympus Corporation, a global MedTech company committed to making people’s lives healthier, safer and more […]

Diseases

 Lung Cancer Awareness Month Highlights Importance of Preventive Screenings | PTF

Lung Cancer Awareness Month Highlights Importance of Preventive Screenings

November 23 2022

Advancements in staging and personalized treatments have helped improve lung cancer survival rates, but low […]

Diseases

 Olympus Launches THUNDERBEAT Energy Device for Open Surgery | Pharmtech Focus

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

September 29 2022

Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer, and […]

Fundraising

 Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership | Pharmtech Focus

Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership

November 12 2021

Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of […]

Equipment

 Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices | Pharmtech Focus

Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices

September 21 2021

Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first […]